Cyclosporin derivatives for treating inflammatory diseases and conditions
AssigneeAllergan, Inc.
InventorsMichael E. Garst, Michael E. Stern
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for the treatment of inflammatory diseases and/or conditions, e.g. allergic conjunctivitis, uveitis or phacoanaphylactic endophthalmitis in an eye of a mammal, said method comprising administering to said mammal in need of treatment a therapeutically effective amount of a novel cyclosporin A derivative selected from the group consisting of compounds represented by the formula: wherein R1 is S-Alk-R wherein Alk is an alkylene linkage, preferably a methylene or poly methylene linkage, or a polyalkenylene linkage, e.g. a C3 to C6 alkenylenyl linkage and R is a hydrogen or a unsubstituted or substituted hydrocarbyl group.
Claims1
A method for the treatment of an inflammatory condition of a mammal, comprising the step of administering to a patient in need thereof, a therapeutically effective amount of a cyclosporin A derivative represented by the following formula:
- wherein R1 is S-Alk-R wherein Alk is an alkylene linkage and R is a hydrogen or a unsubstituted or substituted hydrocarbyl group.
Dependencies are inferred from the claim text.